Donate For Public and Patients Store Search

F120 - Dermatologic Side Effects of Anticancer Drugs in 2019: What You Need to Know

Monday, March 4; 9:00 AM - 11:00 AM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize the impact on quality of life and clinical characteristics of dermatologic diverse events to novel cancer therapies.
  • Describe the mechanisms involved in dermatologic adverse events to novel cancer therapies.
  • Discuss novel interventions towards dermatologic adverse events in cancer patients.

Description

This session is directed towards dermatologists involved in the care of patients that are being treated with novel agents including targeted therapies and immune checkpoint inhibitors that have revolutionized cancer care. The session will include mechanisms to prevent and treat these untoward events, in order to maintain quality of life and consistent dosing of cancer therapies. In addition, strategies to prevent chemotherapy-induced alopecia will be described, which have increased the awareness of skin, hair, and nail disorders in oncology, and place dermatologists as an integral part of comprehensive cancer care.

Disclosures

  • Kwong, Bernice, MD: Genentech, Inc. – C(Fees);
  • Lacouture, Mario E., MD: AbbVie – C(H); ADC Therapeutics – C(H); Adgero Biopharmaceuticals Holdings, Inc. – C(H); Astellas Pharma US, Inc – C(H); Celldex – C(H); Galderma Research & Development, LLC – C(H); Harborside – O(Fees); Helsinn Healthcare – C(H); Johnson and Johnson – C(H); Lindiskin – C(H); Menlo Therapeutics – C(H); Merck & Co., Inc – C(H); Novartis – C(H); Novocure – C(H); Wiley & Sons, Inc. – O(Fees);
  • Larocca, Cecilia, MD: no financial relationships exist with commercial interests.
  • van den Hurk, Corina, PhD: Dignitana – I(Grants/Research Funding); Paxman – I(Grants/Research Funding), SP(OB);
Schedule
Monday, March 4
9:00 AM
Dr. Larocca / Treatments for Solid Tumors
9:30 AM
Dr. Kwong / Treatments for Hematologic Cancers
10:00 AM
Dr. Lacouture / Immune Checkpoint Inhibitors
10:30 AM
van den Hurk / Scalp Cooling for Chemotherapy Alopecia
Event Details
  • Date
    Monday, March 4
  • Time
    9:00 AM - 11:00 AM
  • Location
    Room 201
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • Mario E. Lacouture, MD, FAAD
Speakers
  • Bernice Kwong, MD, FAAD
  • Cecilia Larocca, MD, FAAD
  • Corina van den Hurk, PhD